Ascentage Pharma Group International (NASDAQ:AAPG) Now Covered by JPMorgan Chase & Co.

JPMorgan Chase & Co. started coverage on shares of Ascentage Pharma Group International (NASDAQ:AAPG) in a research report sent to investors on Thursday morning, MarketBeat.com reports. The brokerage issued an overweight rating on the stock.

Ascentage Pharma Group International Trading Up 10.0 %

Shares of AAPG opened at $20.20 on Thursday. Ascentage Pharma Group International has a twelve month low of $16.50 and a twelve month high of $21.40.

About Ascentage Pharma Group International

Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.